About the Company
adc therapeutics is a biotechnology company located in lausanne, vaud, switzerland.
Please visit adctherapeutics.com for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ADCT News
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call March 13, 2024 ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, ...
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $16.6 million in 4Q 2023 and $69.1 million for full year (FY) 2023; 4Q ...
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
ADC Therapeutics SA (ADCT) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.30 per share a year ago. These figures ...
ADC Therapeutics SA ADCT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
ZYNLONTA ® (loncastuximab tesirine-lpyl) net sales of $16.6 million in 4Q 2023 and $69.1 million for full year (FY) 2023; 4Q sales grew sequentially in both academic and community settings ...
ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript
Welcome to the ADC Therapeutics Fourth Quarter and Full-Year 2023 Financial Results Conference Call. My name is Norma and I will be your operator for today's call. At this time, all participants ...
Q4 2023 ADC Therapeutics SA Earnings Call
Naureen Quibria; Analyst; Capital One Securities, Inc. Brian Cheng; Analyst; JPMorgan Chase & Co. Greg Renza; Analyst; RBC Capital Markets Kelly Shi; Analyst; Jefferies Financial Group Inc Welcome to ...
Loading the latest forecasts...